Literature DB >> 31310176

Cross-sectional CT Assessment of the Extent of Injectate Spread at CT Fluoroscopy-guided Cervical Epidural Interlaminar Steroid Injections.

Timothy J Amrhein1, Erol Bozdogan1, Sunit Vekaria1, Prasad Patel1, Reginald Lerebours1, Sheng Luo1, Peter G Kranz1.   

Abstract

Background Previous studies analyzed contrast agent spread during cervical interlaminar epidural steroid injections (CILESIs) by using planar fluoroscopy and reported wide variance of the rate of spread to the ventral epidural space (VES). Cross-sectional CT allows for direct viewing of contrast agent in the VES, providing improved spread assessment and thereby informing needle placement decisions when targeting pain generators. Purpose To determine the extent of injectate spread at CT fluoroscopy-guided CILESI, with particular attention to the VES and bilateral neuroforamina, by using cross-sectional CT. Materials and Methods This study reviewed 83 consecutive CT fluoroscopy-guided CILESIs at which a postprocedural cervical spine CT was performed (June 2016 to December 2017). All procedures used the same injectate (2 mL corticosteroid, 3 mL contrast agent). Postprocedural CT scans were reviewed for the presence of contrast within the VES, dorsal epidural space, ipsilateral neuroforamen, and contralateral neuroforamen in every cervical interlaminar level. Descriptive data are presented as frequencies or means. McNemar tests or hierarchical logistic models were used to assess associations between covariates and contrast agent spread to particular locations. Results The study cohort included 73 individual patients (59% women; 43 of 73) (mean patient age, 57.6 years ± 11.5 [standard deviation]). Mean number of levels of cranial spread were 0.6 level for VES, 1.9 levels for contralateral neuroforamen, 2.1 levels for ipsilateral neuroforamen, and 3 levels for dorsal epidural space. No VES spread in any level was found with 35% (29 of 83) of injections. VES spread was more likely to occur in the level of needle placement (43%; 36 of 83) than in other interlaminar levels (19.5%; 97 of 498; P < .001). Spread was more likely to occur in the neuroforamen ipsilateral to the needle approach compared with contralateral (P < .001). Conclusion Cervical interlaminar epidural steroid injections have injectate spreads with a mean of less than one level cranially in the ventral epidural space (VES) and approximately two levels in the neuroforamen. VES spread occurs more frequently at the level of needle placement and within the ipsilateral neuroforamen. © RSNA, 2019.

Entities:  

Year:  2019        PMID: 31310176      PMCID: PMC6716562          DOI: 10.1148/radiol.2019182795

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

Review 1.  Cervicogenic headache: evidence that the neck is a pain generator.

Authors:  Werner J Becker
Journal:  Headache       Date:  2010-04       Impact factor: 5.887

2.  Fluoroscopically guided cervical interlaminar epidural injections using the midline approach: an analysis of epidurography contrast patterns.

Authors:  Kwang Su Kim; Sung Sik Shin; Tae Sam Kim; Chang Young Jeong; Myung Ha Yoon; Jeong Il Choi
Journal:  Anesth Analg       Date:  2009-05       Impact factor: 5.108

3.  Comparison of contrast flow and clinical effectiveness between a modified paramedian interlaminar approach and transforaminal approach in cervical epidural steroid injection.

Authors:  E Choi; F S Nahm; P-B Lee
Journal:  Br J Anaesth       Date:  2015-11       Impact factor: 9.166

4.  Contrast flow characteristics in the cervical epidural space: an analysis of cervical epidurograms.

Authors:  Amitabh Goel; Jennifer J Pollan
Journal:  Spine (Phila Pa 1976)       Date:  2006-06-15       Impact factor: 3.468

5.  CT fluoroscopy-guided cervical interlaminar steroid injections: safety, technique, and radiation dose parameters.

Authors:  P G Kranz; P Raduazo; L Gray; R K Kilani; J K Hoang
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

6.  Fluoroscopic transforaminal lumbar epidural steroids: an outcome study.

Authors:  G E Lutz; V B Vad; R J Wisneski
Journal:  Arch Phys Med Rehabil       Date:  1998-11       Impact factor: 3.966

7.  An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations.

Authors:  Laxmaiah Manchikanti; Salahadin Abdi; Sairam Atluri; Ramsin M Benyamin; Mark V Boswell; Ricardo M Buenaventura; David A Bryce; Patricia A Burks; David L Caraway; Aaron K Calodney; Kimberly A Cash; Paul J Christo; Steven P Cohen; James Colson; Ann Conn; Harold Cordner; Sareta Coubarous; Sukdeb Datta; Timothy R Deer; Sudhir Diwan; Frank J E Falco; Bert Fellows; Stephanie Geffert; Jay S Grider; Sanjeeva Gupta; Haroon Hameed; Mariam Hameed; Hans Hansen; Standiford Helm; Jeffrey W Janata; Rafael Justiz; Alan D Kaye; Marion Lee; Kavita N Manchikanti; Carla D McManus; Obi Onyewu; Allan T Parr; Vikram B Patel; Gabor B Racz; Nalini Sehgal; Manohar Lal Sharma; Thomas T Simopoulos; Vijay Singh; Howard S Smith; Lee T Snook; John R Swicegood; Ricardo Vallejo; Stephen P Ward; Bradley W Wargo; Jie Zhu; Joshua A Hirsch
Journal:  Pain Physician       Date:  2013-04       Impact factor: 4.965

8.  Lateral parasagittal versus midline interlaminar lumbar epidural steroid injection for management of low back pain with lumbosacral radicular pain: a double-blind, randomized study.

Authors:  Babita Ghai; Kaivalya Sadashiv Vadaje; Jyotsna Wig; Mandeep Singh Dhillon
Journal:  Anesth Analg       Date:  2013-04-30       Impact factor: 5.108

9.  Distribution range of cervical interlaminar epidural injections: a comparative study with 2.5 mL, 5 mL, and 10 mL of contrast.

Authors:  Sang Eun Lee; Han Bum Joe; Jae Hong Park; In Kyong Yi; Yi Hwa Choi; Kyung Ream Han; Chan Kim
Journal:  Pain Physician       Date:  2013 Mar-Apr       Impact factor: 4.965

10.  Optimal volume of injectate for fluoroscopy-guided cervical interlaminar epidural injection in patients with neck and upper extremity pain.

Authors:  Jun Young Park; Doo Hwan Kim; Kunhee Lee; Seong-Soo Choi; Jeong-Gil Leem
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.